Baxter

Tue, 05/26/2009 - 05:59 By Sabine Vollmer

Talecris sale to be blocked

The $3.1 billion offer for Talecris Biotherapeutics, one of the Triangle's largest drugmaker, raised antitrust questions from the very beginning.